April 23, 2026

Vanderbilt Health implants novel device to treat aortic regurgitation in high-risk patients

With the addition of the J-Valve device, Vanderbilt Health now offers minimally invasive procedures to implant devices treating every valve disease. The trial is still enrolling new patients, so other high-risk patients with aortic regurgitation could qualify.

By Matt Batcheldor

November 4, 2025

VUMC performs minimally invasive transcatheter tricuspid valve replacement for recent heart transplant recipient

The team used an artificial tricuspid valve, EVOQUE, which received Food and Drug Administration approval in February.

By Jill Clendening